The global Human Growth Hormone (hGH) market size is predicted to grow from US$ 4814 million in 2025 to US$ 5938 million in 2031; it is expected to grow at a CAGR of 3.6% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Growth hormone (GH), also known as somatotropin (or as human growth hormone in its human form), is a peptide hormone that stimulates growth, cell reproduction, and cell regeneration in humans and other animals. It is thus important in human development. It is a type of mitogen which is specific only to certain kinds of cells. Growth hormone is a 192-amino acid, single-chain polypeptide that is synthesized, stored, and secreted by somatotropic cells within the lateral wings of the anterior pituitary gland.

For industry structure analysis, the Human Growth Hormone industry is very concentrated. These manufacturers ranging from large multinational corporations to small privately owned companies compete in this industry. The top five producers include Novo Nordisk, Pfizer, Eli Lilly, Merck Serono and F. Hoffmann-La Roche, account for more than 80% of the revenue market. Regionally, North America is the biggest production value area of valves, also the leader in the whole Human Growth Hormone industry.

North America occupied 42% of the production market. It is followed by Europe and China, which respectively have around 27% and 16% of the global total industry. Other countries have a small amount of production. Geographically, North America was the largest consumption market in the world, which took about 44.60% of the global consumption volume.

Infinity Market Research newest research report, the Human Growth Hormone (hGH) Industry Forecast looks at past sales and reviews total world Human Growth Hormone (hGH) sales in 2024, providing a comprehensive analysis by region and market sector of projected Human Growth Hormone (hGH) sales for 2025 through 2031. With Human Growth Hormone (hGH) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Growth Hormone (hGH) industry.

This Insight Report provides a comprehensive analysis of the global Human Growth Hormone (hGH) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Growth Hormone (hGH) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Human Growth Hormone (hGH) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Growth Hormone (hGH) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Growth Hormone (hGH).

This report presents a comprehensive overview, market shares, and growth opportunities of Human Growth Hormone (hGH) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Powder
    Solvent

Segmentation by Application:

    Growth Hormone Deficiency
    Turner Syndrome
    Idiopathic Short Stature
    Prader-Willi Syndrome
    Small for Gestational Age
    Others

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Merck?Co.?Inc
    Eli Lilly and Company
    Genentech?Inc.
    Novo Nordisk
    Sandoz International GmbH
    Ferring Holding SA
    Ipsen

Key Questions Addressed in this Report

What is the 10-year outlook for the global Human Growth Hormone (hGH) market?
What factors are driving Human Growth Hormone (hGH) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human Growth Hormone (hGH) market opportunities vary by end market size?
How does Human Growth Hormone (hGH) break out by Type, by Application?